New treatment option for Healthy Volunteers
Official title Showers and Stress
ClinicalTrials.gov ID: NCT07611422
What this study is testing
- What it's testing
- The study investigates whether repeated exposure to cold showers can improve the ability to cope with and respond to stress. In particular, it examines both the psychophysiological effects of cold showers and the role of expectations regarding their effectiveness.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Participants will be eligible for the study if they meet the following criteria:
- Age ≥ 18 years
- Good general health status, self-reported and/or certified by a medical document (e.g., general medical certificate or sports medical clearance)
- Willingness to participate for the full duration of the study (4 weeks)
- Ability to understand and independently complete questionnaires and study diaries
You likely can't join if
- Participants will be excluded from the study if they present:
- Uncompensated cardiovascular, neurological, or endocrine conditions considered relevant to stress or cold exposure tolerance
- Medical conditions contraindicating cold exposure (e.g., Raynaud's phenomenon, cold urticaria, etc.)
- Pregnancy
- Use of medications that may interfere with stress responses (e.g., beta-blockers, anxiolytics, systemic corticosteroids)
- Acute or unstable psychiatric disorders
See the full eligibility criteria
- Participants will be eligible for the study if they meet the following criteria:
- Age ≥ 18 years
- Good general health status, self-reported and/or certified by a medical document (e.g., general medical certificate or sports medical clearance)
- Willingness to participate for the full duration of the study (4 weeks)
- Ability to understand and independently complete questionnaires and study diaries
- Signed informed consent
- Participants will be excluded from the study if they present:
- Uncompensated cardiovascular, neurological, or endocrine conditions considered relevant to stress or cold exposure tolerance
- Medical conditions contraindicating cold exposure (e.g., Raynaud's phenomenon, cold urticaria, etc.)
- Pregnancy
- Use of medications that may interfere with stress responses (e.g., beta-blockers, anxiolytics, systemic corticosteroids)
- Acute or unstable psychiatric disorders
- Inability to comply with the experimental protocol or complete study materials
- Concurrent participation in other studies involving stress or physiological regulation interventions
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.